Key result
Systematic functional and molecular evaluation of patients with suspected inherited platelet disorders confirmed the diagnosis in 67.1% of cases, identified 12 novel mutations, and revealed that 32.9% had been previously misdiagnosed.
Observational (n=70)
Yes
Systematic functional and molecular characterization of patients with suspected inherited platelet disorders identified 12 novel mutations and revealed a misdiagnosis rate of nearly 33% in non-specialized centers.
Specialized referral may curb misdiagnoses in suspected inherited platelet disorders; extends mutation spectrum but leaves open outcome impact.
BACKGROUND: The diagnostic evaluation of inherited platelet disorders (IPDs) is complicated and time-consuming, resulting in a relevant number of undiagnosed and incorrectly classified patients. In order to evaluate the spectrum of IPDs in individuals with clinical suspicion of these disorders, and to provide a diagnostic tool to centers not having access to specific platelets studies, we established the project "Functional and Molecular Characterization of Patients with Inherited Platelet Disorders" under the scientific sponsorship of the Spanish Society of Thrombosis and Haemostasis. PATIENTS/METHODS: Subjects were patients from a prospective cohort of individuals referred for clinical suspicion of IPDs as well as healthy controls. Functional studies included light transmission aggregation, flow cytometry, and when indicated, Western-blot analysis of platelet glycoproteins, and clot retraction analysis. Genetic analysis was mainly performed by sequencing of coding regions and proximal regulatory regions of the genes of interest. RESULTS: Of the 70 cases referred for study, we functionally and molecularly characterized 12 patients with Glanzmann Thrombasthenia, 8 patients with Bernard Soulier syndrome, and 8 with other forms of IPDs. Twelve novel mutations were identified among these patients. The systematic study of patients revealed that almost one-third of patients had been previously misdiagnosed. CONCLUSIONS: Our study provides a global picture of the current limitations and access to the diagnosis of IPDs, identifies and confirms new genetic variants that cause these disorders, and emphasizes the need of creating reference centers that can help health care providers in the recognition of these defects.
No takes yet. Share an insight, caveat, or question.
Sánchez‐Guiu et al. (2014) conducted an observational in Inherited platelet disorders (n=70). Systematic functional and molecular diagnostic evaluation vs. Previous clinical diagnosis was evaluated on Confirmation of inherited platelet disorder diagnosis. Systematic functional and molecular evaluation of patients with suspected inherited platelet disorders confirmed the diagnosis in 67.1% of cases, identified 12 novel mutations, and revealed that 32.9% had been previously misdiagnosed.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: